Stocks to Watch: Energy Transfer Equity, L.P. (NYSE:ETE), Nokia Corporation (ADR) (NYSE:NOK), Jazz Pharmaceuticals (NASDAQ:JAZZ), Books-A-Million Inc. (NASDAQ:BAMM), Convergys Corporation (NYSE:CVG)

Energy Transfer Equity, L.P. (NYSE:ETE) reported financial results for the quarter ended June 30, 2015.Distributable Cash Flow, as adjusted, for the three months ended June 30, 2015 was $335 million compared to $218 million for the three months ended June 30, 2014, an increase of $117 million. Distributable Cash Flow, as adjusted, per unit was $0.31 for the three months ended June 30, 2015, an increase of 55% compared to the three months ended June 30, 2014. ETE’s net income attributable to partners was $298 million for the three months ended June 30, 2015 compared to $164 million for the three months ended June 30, 2014, an increase of $134 million. Energy Transfer Equity, L.P. (NYSE:ETE) belongs to Basic Materials sector. Its net profit margin is 1.40% and weekly performance is -8.12%. On last trading day company shares ended up $27.39. Energy Transfer Equity, L.P. (NYSE:ETE) distance from 50-day simple moving average (SMA50) is -14.04%.

Nokia Corporation (ADR) (NYSE:NOK) has recently revealed a new camera for the filmmakers around the world that the company is calling OZO that is fully equipped to capture virtual reality videos. However, unlike those that were unveiled by GoPro and Samsung in the past months, the OZO isn’t just a flattened circle that has cameras. Instead, it’s a spherical ball-shaped device that has got shutters all over its body. Nokia Corporation (ADR) (NYSE:NOK) shares fell -0.44% in last trading session and ended the day at $6.78. NOK Gross Margin is 44.30% and its return on assets is 26.80%. Nokia Corporation (ADR) (NYSE:NOK) quarterly performance is -2.16%.

Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ) announced financial results for the second quarter of 2015 and reaffirmed financial guidance for 2015. Our second quarter results reflect strong top- and bottom-line growth, strong margins, and continued investment in our commercial and R&D portfolios to support our long-term growth strategy,” said Bruce C. Cozadd, chairman and chief executive officer of Jazz Pharmaceuticals plc. “We made significant progress toward this year’s research and development goals with the completion of the rolling NDA submission for defibrotide and the initiation of enrollment in our Phase 3 program to evaluate the role of JZP-110 in the treatment of excessive daytime sleepiness in patients with narcolepsy or obstructive sleep apnea. On 07 August, Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ) shares fell -1.33% and was closed at $181.79. JAZZ EPS growth in last 5 year was 43.30%. Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ) year to date (YTD) performance is 11.03%.

Rigrodsky & Long, P.A. announces that it is investigating potential legal claims against the board of directors of Books-A-Million Inc. (NASDAQ:BAMM) regarding possible breaches of fiduciary duties and other violations of law related to the Company’s entry into an agreement to be acquired by an entity owned by the Anderson Family, including Clyde B. Anderson, Executive Chairman of the Company, and related persons and entities (collectively, the “Anderson Famly”), in a transaction valued at approximately $21 million. Books-A-Million Inc. (NASDAQ:BAMM) ended the last trading day at $3.21. Company weekly volatility is calculated as 0.94% and price to cash ratio as 6.97. Books-A-Million Inc. (NASDAQ:BAMM) showed a weekly performance of -0.62%.

Convergys Corporation (NYSE:CVG) announced its financial results for the second quarter of 2015. Revenue was $717 million including $22 million adverse foreign currency impacts, a 3 percent decrease as reported and a slight increase on a constant currency basis, compared with $736 million in the same period last year. Adjusted operating income was $51 million, compared with $53 million in the same period last year. Including certain acquisition-related and other impacts discussed below, GAAP operating income was $36 million, compared with $37 million in the same period last year. Convergys Corporation (NYSE:CVG) shares fell -0.38% in last trading session and ended the day at $23.41. CVG Gross Margin is 36.20% and its return on assets is 5.70%. Convergys Corporation (NYSE:CVG) quarterly performance is -1.24%.

Leave a Reply

Your email address will not be published. Required fields are marked *